Hamilton Thorne Announces the Acquisition of Microptic, S.L.
BEVERLY, Mass. and TORONTO, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL) ("Hamilton Thorne" or the "Company"), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies ("ART") research, and cell biology markets, today announced that it has closed the acquisition (the "Transaction") of Microptic, S.L. ("Microptic") effective as of November 30, 2022.
- The Transaction expands Hamilton Thorne's product offerings and provides the Company with profitable operations in the well-established European ART market.
- Key Benefits of the Transaction:
"We are excited to welcome our new partners from Microptic to the Hamilton Thorne family. - This acquisition enhances our product offerings in AI enabled CASA software, image analysis systems, consumables, and related products.
- Hamilton Thorne markets its products and services under the Hamilton Thorne, Gynemed, Planer, IVFtech, Embryotech Laboratories, Tek-Event brands, and Microptic, through its growing sales force and distributors worldwide.